Tenofovir alafenamide versus tenofovir disoproxil fumarate, coformulated with elvitegravir, cobicistat, and emtricitabine, for initial treatment of HIV-1 infection: two randomised, double-blind, phase 3, non-inferiority trials (Q41044551)
Jump to navigation
Jump to search
scientific article published on 15 April 2015
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Tenofovir alafenamide versus tenofovir disoproxil fumarate, coformulated with elvitegravir, cobicistat, and emtricitabine, for initial treatment of HIV-1 infection: two randomised, double-blind, phase 3, non-inferiority trials |
scientific article published on 15 April 2015 |
Statements
1 reference
Tenofovir alafenamide versus tenofovir disoproxil fumarate, coformulated with elvitegravir, cobicistat, and emtricitabine, for initial treatment of HIV-1 infection: two randomised, double-blind, phase 3, non-inferiority trials (English)
1 reference
Daniel Podzamczer
1 reference
Paul E Sax
1 reference
Michael Saag
1 reference
Jean Michel Molina
1 reference
Benoit Trottier
1 reference
Christian Callebaut
1 reference
David Wohl
1 reference
Michael T Yin
1 reference
Frank Post
1 reference
Edwin DeJesus
1 reference
Anton Pozniak
1 reference
Melanie Thompson
1 reference
Shinichi Oka
1 reference
Ellen Koenig
1 reference
Jaime Andrade-Villanueva
1 reference
Gordon Crofoot
1 reference
Joseph M Custodio
1 reference
Andrew Plummer
1 reference
Lijie Zhong
1 reference
Huyen Cao
1 reference
Hal Martin
1 reference
Andrew K Cheng
1 reference
Marshall W Fordyce
1 reference
Scott McCallister
1 reference
GS-US-292-0104/0111 Study Team
1 reference
15 April 2015
1 reference
1 reference
2606-2615
1 reference
Identifiers
1 reference